H.R. 2438 - To Amend the Federal Food, Drug, and Cosmetic Act with Respect to Broader Application of Bayesian Statistics and Adaptive Trial Designs.

To Amend the Federal Food, Drug, and Cosmetic Act with Respect to Broader Application of Bayesian Statistics and Adaptive Trial Designs.

H.R. 2438 — 114^th Congress (2015–2016)

Summary

To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial designs. (by CRS)

Learn More

At OpenCongress

Title

To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial designs.

Other Titles

• To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial designs.

Sponsor

Chris Collins

Co-Sponsors

Subjects

• Health
• Administrative law and regulatory procedures
• Department of Health and Human Services
• Drug safety, medical device, and laboratory regulation
• Food and Drug Administration (FDA)
• Medical research

Related Bills

• H.R. 6 (114^th) : 21st Century Cures Act

Major Actions

Introduced	5/19/2015
Referred to Committee

Bill History

• All Votes
• All Actions
• Amendments

There have been no votes on this bill.

	Action	Date	Description
	Introduced	5/19/2015
		5/19/2015	Referred to the House Committee on Energy and Commerce.
		5/19/2015	Introduced in House
		5/22/2015	Referred to the Subcommittee on Health.

	Number	Sponsor	Date Offered	Status